Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
HIV Clinical Trials
|
May 14, 2008
Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353
Y J Bryson, M Mirochnick, A Stek, et al.
The Journal of Infectious Diseases
|
February 15, 2001
Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml
J P Ioannidis, E J Abrams, A Ammann, et al.
The Journal of Infectious Diseases
|
February 1, 1997
Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study Group
J S Lambert, L M Mofenson, C V Fletcher, et al.
The New England Journal of Medicine
|
December 22, 1999
Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team
S E Starr, C V Fletcher, S A Spector, et al.
The Journal of Infectious Diseases
|
February 11, 2000
Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273)
E R Stiehm, C V Fletcher, L M Mofenson, et al.
The Journal of Infectious Diseases
|
February 10, 1999
Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185
E R Stiehm, J S Lambert, L M Mofenson, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
HIV Clinical Trials
|
May 14, 2008
Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353
Y J Bryson, M Mirochnick, A Stek, et al.
The Journal of Infectious Diseases
|
February 15, 2001
Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml
J P Ioannidis, E J Abrams, A Ammann, et al.
The Journal of Infectious Diseases
|
February 1, 1997
Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study Group
J S Lambert, L M Mofenson, C V Fletcher, et al.
The New England Journal of Medicine
|
December 22, 1999
Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team
S E Starr, C V Fletcher, S A Spector, et al.
The Journal of Infectious Diseases
|
February 11, 2000
Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273)
E R Stiehm, C V Fletcher, L M Mofenson, et al.
The Journal of Infectious Diseases
|
February 10, 1999
Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185
E R Stiehm, J S Lambert, L M Mofenson, et al.
Page
of 5